Viruses resistant to Tamiflu identified

Several cases of the H1N1 ‘swine flu’ virus have emerged that are resistant to antiviral drug Tamiflu (oseltaminvir). WHO has been informed by...

Novo Nordisk launches Victoza in UK

Novo Nordisk’s Victoza is now available for type 2 diabetes patients in the UK, following EU approval. Victoza is the first once-daily human Glucagon-like...

Novartis joins fight against malaria

Novartis has become the first healthcare company to join United Against Malaria (UAM), a pan-Africa campaign to end malaria-related deaths and suffering by 2015....

Best-selling drugs cheaper in Europe

European prices of 170 best-selling drugs averaged 40% less than US prices in 2008, recent research has revealed. Within Europe, it was found,...

Study confirms Cervarix efficacy

The largest efficacy trial of a cervical cancer vaccine has shown that Cervarix protects against the five most common cancer-causing virus types. The...

Positive CHMP opinion for Javlor

The CHMP has issued a positive opinion recommending EU marketing authorisation for Javlor from Laboratoires Pierre Fabre. The drug has been recommended for...

EU lung cancer approval for Alimta

Alimta (pemetrexed for injection) has become the first agent approved in Europe as maintenance therapy for advanced, nonsquamous non-small cell lung cancer. The European...

Scientists recognised for Alzheimer’s research

Four scientists have been recognized by the Alzheimer’s Association for their extraordinary achievements in advancing Alzheimer's research at its 2009 International Conference on Alzheimer's...

Big pharma goes legally blonde

Reese Witherspoon is to produce and star in a new comedy about a woman’s career within the drug industry. Currently under development by Universal...

Security,Opportunity,Success: how Ashfield In2Focus can help you build a career

Pharmaceutical companies are downsizing, but one UK company keeps getting bigger. Ashfield In2Focus shows how its commitment to personal and professional development is providing...

Latest articles

Man standing at flipboard with graphs and charts on it to show Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial for bempedoic acid

Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial for bempedoic acid

Daiichi Sankyo Europe GmbH has announced the publication of results from the Phase 3 CLEAR Wisdom trial in the Journal of the American Medical Association...
Patients holding their stomach to show

NICE recommends Consilient Health’s elmiron® for bladder pain syndrome

Consilient Health welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend elmiron® (pentosan polysulfate sodium) for bladder pain...
Image of four people communicating via different mediums to depict mind the Generation Gap in pharma marketing

Mind the generation gap in pharma marketing and market research

Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...

Popular articles

Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Mapping NHS change is key to customer engagement

Mapping NHS change is key to customer engagement

Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Man standing at flipboard with graphs and charts on it to show Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial for bempedoic acid

Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial for bempedoic acid

Daiichi Sankyo Europe GmbH has announced the publication of results from the Phase 3 CLEAR Wisdom trial in the Journal of the American Medical Association...

Market Access in practice: do you have a strategy?

This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription